Clinical Study

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Figure 2

Concentration times time graph of intraperitoneal pemetrexed in peritoneal fluid and plasma in a single patient who had pharmacologic studies of the first and fifth cycle.
890450.fig.002